BioCentury
ARTICLE | Clinical News

Retavase reteplase: Marketed to treat MI

September 10, 2001 7:00 AM UTC

JNJ subsidiary Centocor Inc. reported that allowing pre-hospital treatment of heart attack patients with Retavase shortened the time to treatment with Retavase from a median time of 64 minutes to 31 ...